Spider-Venom Peptides: Structure, Bioactivity, Strategy, and Research Applications
Guo, RY; Guo, G; Wang, AL; Xu, GC; Lai, R; Jin, H
2024
发表期刊MOLECULES
ISSN1420-3049
卷号29期号:1
摘要Spiders (Araneae), having thrived for over 300 million years, exhibit remarkable diversity, with 47,000 described species and an estimated 150,000 species in existence. Evolving with intricate venom, spiders are nature's skilled predators. While only a small fraction of spiders pose a threat to humans, their venoms contain complex compounds, holding promise as drug leads. Spider venoms primarily serve to immobilize prey, achieved through neurotoxins targeting ion channels. Peptides constitute a major part of these venoms, displaying diverse pharmacological activities, and making them appealing for drug development. Moreover, spider-venom peptides have emerged as valuable tools for exploring human disease mechanisms. This review focuses on the roles of spider-venom peptides in spider survival strategies and their dual significance as pharmaceutical research tools. By integrating recent discoveries, it provides a comprehensive overview of these peptides, their targets, bioactivities, and their relevance in spider survival and medical research.
收录类别sci
语种英语
文献类型期刊论文
条目标识符http://ir.kiz.ac.cn/handle/152453/14218
专题科研部门_天然药物功能蛋白质学科组(赖仞)
推荐引用方式
GB/T 7714
Guo, RY,Guo, G,Wang, AL,et al. Spider-Venom Peptides: Structure, Bioactivity, Strategy, and Research Applications[J]. MOLECULES,2024,29(1).
APA Guo, RY,Guo, G,Wang, AL,Xu, GC,Lai, R,&Jin, H.(2024).Spider-Venom Peptides: Structure, Bioactivity, Strategy, and Research Applications.MOLECULES,29(1).
MLA Guo, RY,et al."Spider-Venom Peptides: Structure, Bioactivity, Strategy, and Research Applications".MOLECULES 29.1(2024).
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
2024073111.pdf(2991KB)期刊论文出版稿开放获取CC BY-NC-SA请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Guo, RY]的文章
[Guo, G]的文章
[Wang, AL]的文章
百度学术
百度学术中相似的文章
[Guo, RY]的文章
[Guo, G]的文章
[Wang, AL]的文章
必应学术
必应学术中相似的文章
[Guo, RY]的文章
[Guo, G]的文章
[Wang, AL]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。